Greg Batcheller

Greg Batcheller holds extensive leadership roles in various organizations, currently serving as a member of the Board of Directors at SAGA Dx Inc and as Chairman at multiple companies including Intellego Technologies AB, Edvince AB, Pharmacyl AB, Targinta AB, CarryGenes Group, and Xintela AB. Additionally, Greg is a Director at Canacyl AB and has been with Business Research Life Sciences Ltd since 2015. Educational qualifications include a B.Sc. in International Relations from The London School of Economics and Political Science, a Master of Laws in European Union Law from Lund University, and a Doctor of Law from the University of Toronto.